STOCK TITAN

Celularity (CELU) holder reports 0% ownership in new Schedule 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Celularity Inc. received Amendment No. 1 to a Schedule 13G from Lincoln Alternative Strategies LLC regarding its Class A common stock. The filer now reports beneficial ownership of 0 shares, representing 0% of the class, and indicates ownership of five percent or less of the stock. The certification states the securities were not acquired and are not held to change or influence control of Celularity and are not part of any control-related transaction.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Lincoln Alternative Strategies LLC
Signature:/s/ Stephen Temes
Name/Title:Stephen Temes/Managing Member
Date:02/11/2026

FAQ

What does Lincoln Alternative Strategies LLC report in its Celularity (CELU) Schedule 13G/A?

Lincoln Alternative Strategies LLC reports beneficial ownership of 0 Celularity shares, or 0% of the class. The filing states it no longer holds voting or dispositive power over any Class A common stock and confirms ownership of five percent or less of the class.

What type of Celularity (CELU) securities are covered in this Schedule 13G/A?

The Schedule 13G/A covers Celularity Inc. Class A common stock, $0.0001 par value per share. The filing identifies this specific class as the relevant security and references the associated CUSIP number 151190204 for clarity on the securities reported.

How much voting and dispositive power does Lincoln Alternative Strategies LLC report over Celularity (CELU) shares?

The filer reports zero voting and zero dispositive power over Celularity shares. It lists sole and shared voting power as 0 and sole and shared dispositive power as 0, aligning with the reported aggregate beneficial ownership of 0 shares and 0% of the class.

What ownership percentage of Celularity (CELU) does Lincoln Alternative Strategies LLC now report?

Lincoln Alternative Strategies LLC reports owning 0% of Celularity’s Class A common stock. The filing explicitly states the aggregate amount beneficially owned is 0 shares, representing 0 percent of the class, and notes ownership of five percent or less of the class.

Does the Schedule 13G/A for Celularity (CELU) indicate an attempt to influence control of the company?

The filer certifies the securities were not acquired and are not held to change or influence control of Celularity. It also states the position is not held in connection with any transaction having that purpose or effect, except for certain nomination activities referenced in the certification.

Who signed the Celularity (CELU) Schedule 13G/A on behalf of Lincoln Alternative Strategies LLC?

The Schedule 13G/A was signed by Stephen Temes as Managing Member of Lincoln Alternative Strategies LLC. The signature block includes his name, title, and a dated certification that the information provided in the statement is true, complete, and correct to the best of his knowledge.
Celularity Inc

NASDAQ:CELU

CELU Rankings

CELU Latest News

CELU Latest SEC Filings

CELU Stock Data

36.05M
16.82M
50.57%
13.14%
6.33%
Biotechnology
Pharmaceutical Preparations
Link
United States
FLORHAM PARK